Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Amerikaanse aandelen Terug naar discussie overzicht

Cannabis aandelen

8.267 Posts
Pagina: «« 1 ... 245 246 247 248 249 ... 414 »» | Laatste | Omlaag ↓
  1. wuiten001 14 november 2018 18:57
    Harvest One Enters Into Cannabis Extraction Agreement With Valens
    November 14, 2018
    Harvest One Cannabis Inc. (TSXV:HVT) ("Harvest One" or the "Company") is pleased to announce that it has entered into a multi-year Extraction Services Agreement (the "Agreement") with Valens GroWorks Corp. (CSE: VGW) ("Valens") for cannabis extraction and value-added services.
    Under the terms of the Agreement, Harvest One’s subsidiary, United Greeneries, will ship bulk quantities of dried cannabis to Valens over an initial three-year term. Valens will process the cannabis on a fee-for-service basis into bulk resin or other cannabis oil derivative products.
    As a component of the Company’s product development strategy, Valens will also conduct R&D to support the expansion of Harvest One’s product lines including health and wellness products, beverages, vape pens, and nutraceuticals using cannabis oil derivative products. The significance of these products is reflected in the more developed markets in the US where raw flower makes up less than half of the products sold.
    “This agreement with Valens represents a valuable opportunity to accelerate Harvest One’s product development strategy,” said Grant Froese, CEO of Harvest One. “We are excited to leverage Valens’ industry leading expertise to further expand our recreational, and health and wellness products, under United Greeneries, Satipharm and Dream Water. Furthermore, this partnership gives Harvest One the ability to diversify our medical product offerings to better serve our patients.”
    “We are excited for the opportunity to utilize our extraction services and R&D technology platform to support Harvest One in delivering innovative, high quality consumer packaged goods to the market,” said Tyler Robson, CEO of Valens GroWorks Corp. “Valens’ expertise in both cannabis extraction and cannabis derivatives offers Harvest One a competitive advantage in the marketplace, especially considering the proven consumer uptake and shelf life stability benefits we are able to make available through the use of SoRSE™ technology. The team at Valens intends to work closely with Harvest One to put the best possible products on the shelves for Canadian consumers.”
    About Valens GroWorks
    Valens GroWorks Corp. is a research-driven, vertically integrated provider of Canadian cannabis company focused on downstream secondary extraction methodology, distillation and cannabinoid isolation and purification, with three wholly-owned subsidiaries located in and around Kelowna, BC. Subsidiary Valens Agritech (“VAL”) holds a license to cultivate and produce oil as a Licensed Producer (“LP”) under the ACMPR, and a Dealer’s License under Health Canada. VAL also has a supply agreement with Canopy Growth Corporation under their extensive CraftGrow distribution network. Subsidiary Valens Labs is a Health Canada licensed ISO 17025 accredited cannabis testing lab providing sector-leading analytical services and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant Based Science. Subsidiary Valens Farms is in the process of becoming a purpose-built facility in compliance with European Union (EU) Good Manufacturing Practices (GMP) standards, ensuring the product from this facility can be exported anywhere in the world where Cannabis is nationally legal for medical or adult usage purposes. For more information, please visit valensgroworks.com. The Company’s investor deck can be found specifically at valensgroworks.com/investors/
  2. Empros 14 november 2018 20:01
    quote:

    rider13 schreef op 14 november 2018 19:57:

    [...]

    Bedankt! Ben eens benieuwd naar hun resultaten.
    Ik denk dat we relatief aangenaam verrast zullen zijn !
  3. [verwijderd] 14 november 2018 20:19
    Breken we echt de 8 cad of 6 $ grens bij Aurora. 100$ bij tilray 10 cad bij cronos en 5 cad bij Organigram
    Het zijn weerstandsniveau's maar shorters hebben alle macht en zijn hebzuchtige roofdieren die tijd hebben. Niets blijft dalen en niets blijft stijgen. Wat snel daalt , snel stijgt Er komen koopjes jagers en er komt ook een opvering die zal worden gebroken door shorters. Tenzij ze even loslaten en long gaan. De stijging was er over, de daling evenzeer.
  4. Weetwel 14 november 2018 21:52
    quote:

    rider13 schreef op 14 november 2018 10:52:

    Nog steeds mijn dividend van Aurora nog niet ontvangen..
    idem, bij welke broker zit je? hier Binck
  5. Rider 15 november 2018 00:08
    quote:

    Weetwel schreef op 14 november 2018 21:52:

    [...]

    idem, bij welke broker zit je? hier Binck
    Ook Binck..
  6. [verwijderd] 15 november 2018 08:42
    De resultaten zijn bekend van de grootste bedrijven. Zijn er conclusies te trekken? Voorbeeld Tilray stelt teleur en heeft veel minder voorraden en verkoopovereenkomsten om vooral Aurora bij te benen. Aurora lijkt op de meeste vlakken er het beste voor te staan. Graag toekomst gerichte meningen seekingalpha.com/article/4222190-tilr...
  7. Rider 15 november 2018 16:10
    Een klein beetje groen voorlopig.. Eerst zal de s&p 500 weer moeten stijgen voor we weer echt kunnen stijgen. Jammer genoeg veel zever rond de brexit.
8.267 Posts
Pagina: «« 1 ... 245 246 247 248 249 ... 414 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.087
AB InBev 2 5.525
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.801
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.755
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.755
Aedifica 3 923
Aegon 3.258 322.940
AFC Ajax 538 7.088
Affimed NV 2 6.297
ageas 5.844 109.895
Agfa-Gevaert 14 2.051
Ahold 3.538 74.343
Air France - KLM 1.025 35.131
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.043
Alfen 16 24.974
Allfunds Group 4 1.508
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.825
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.444
AMG 971 133.855
AMS 3 73
Amsterdam Commodities 305 6.697
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.026
Apollo Alternative Assets 1 17
Apple 5 384
Arcadis 252 8.787
Arcelor Mittal 2.034 320.824
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.328
Aroundtown SA 1 219
Arrowhead Research 5 9.745
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.363
ASML 1.766 108.459
ASR Nederland 21 4.502
ATAI Life Sciences 1 7
Atenor Group 1 521
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.688
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.404

Macro & Bedrijfsagenda

  1. 06 maart

    1. Air France-KLM Q4-cijfers
    2. Lufthansa Q4-cijfers
    3. Deutsche Post Q4-cijfers
    4. Merck KGaA Q4-cijfers
    5. Zalando Q4-cijfers
    6. Eurocommercial Properties Q4-cijfers
    7. Detailhandelsverkopen januari (eur)
    8. Macy's Q4-cijfers
    9. JD.com Q4-cijfers
    10. Kroger Q4-cijfers
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht